{"organizations": [], "uuid": "940c88c5019da30df7a179f5ba4bf94811a0783c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180409.html", "section_title": "Archive News &amp; Video for Monday, 09 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/ionis-astrazeneca/ionis-to-get-up-to-300-mln-from-licensing-deal-with-astrazeneca-idUSL3N1RM39M", "country": "US", "domain_rank": 408, "title": "Ionis to get up to $300 mln from licensing deal with AstraZeneca", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.16, "site_type": "news", "published": "2018-04-09T19:29:00.000+03:00", "replies_count": 0, "uuid": "940c88c5019da30df7a179f5ba4bf94811a0783c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/ionis-astrazeneca/ionis-to-get-up-to-300-mln-from-licensing-deal-with-astrazeneca-idUSL3N1RM39M", "ord_in_thread": 0, "title": "Ionis to get up to $300 mln from licensing deal with AstraZeneca", "locations": [], "entities": {"persons": [{"name": "mrinalini krothapalli", "sentiment": "none"}, {"name": "sriraj kalluvila", "sentiment": "none"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "ionis pharmaceuticals", "sentiment": "negative"}, {"name": "astrazeneca", "sentiment": "negative"}, {"name": "astrazeneca plc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 9 (Reuters) - Ionis Pharmaceuticals said on Monday it signed a licensing deal for its fatty liver disease treatment with AstraZeneca Plc that could land the company up to $300 million in milestone payments and royalties.\nAstraZeneca will pay Ionis a $30 million license fee based on a certain milestone in development. (Reporting by Mrinalini Krothapalli; Editing by Sriraj Kalluvila)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-09T19:29:00.000+03:00", "crawled": "2018-04-10T13:04:48.017+03:00", "highlightTitle": ""}